Hard to Treat Diseases, Inc. (HTDS)
0.0000
0.00 (0.00%)
USD |
OTCM |
Jan 16, 16:00
Price Chart
Key Stats
| Dividend | |
|---|---|
| Dividend | -- |
| Dividend Yield (Forward) | Upgrade |
| Financials | |
| Revenue (5 Year Growth) | Upgrade |
| Revenue (Quarterly YoY Growth) | Upgrade |
| EPS Diluted (5 Year Growth) | Upgrade |
| EPS Diluted (Quarterly YoY Growth) | Upgrade |
| Debt to Equity Ratio | -- |
| Return on Equity | Upgrade |
| Return on Assets | Upgrade |
| Risk | |
| Beta (5Y) | Upgrade |
| Max Drawdown (5Y) | 100.00% |
Profile
| Hard to Treat Diseases, Inc. engages in the research, development, purchase, sale, and marketing of biological vaccines. The company was founded in 1993 and is headquartered in Clearwater, FL. |
| URL | http://www.htdsmedical.com |
| Investor Relations URL | N/A |
| HQ State/Province | Florida |
| Sector | |
| Industry | |
| Next Earnings Release | N/A |
| Last Earnings Release | N/A |
| Next Ex-Dividend Date | N/A |
| Last Ex-Dividend Date | N/A |
Ratings
Profile
| Hard to Treat Diseases, Inc. engages in the research, development, purchase, sale, and marketing of biological vaccines. The company was founded in 1993 and is headquartered in Clearwater, FL. |
| URL | http://www.htdsmedical.com |
| Investor Relations URL | N/A |
| HQ State/Province | Florida |
| Sector | |
| Industry | |
| Next Earnings Release | N/A |
| Last Earnings Release | N/A |
| Next Ex-Dividend Date | N/A |
| Last Ex-Dividend Date | N/A |